Vivos Therapeutics Inc (VVOS NASDAQ) stock market data APIs
$2.1195
0.14(6.6%)
as of November 20, 2025
Try our APIs with
free plan!
Vivos Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
Prev. Close
2.1195
Open
2.2599
High
2.4897
Low
2.0971
52 wk Range
1.98-7.95
Market Cap
15 910 K
Shares Outstanding
7 505 K
Revenue
14 393 K
EPS
-0.49
Beta
6.841
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vivos Therapeutics Inc data using free add-ons & libraries
Get Vivos Therapeutics Inc Fundamental Data
Vivos Therapeutics Inc Fundamental data includes:
- Net Revenue: 14 393 K
- EBITDA: -13 459 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -0.48
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vivos Therapeutics Inc News
New
Vivos Therapeutics signals continued revenue acceleration amid SCN integration and SAMC expansion plans
Earnings Call Insights: Vivos Therapeutics (VVOS) Q3 2025 MANAGEMENT VIEW * CEO R. Huntsman described Q3 2025 as "a watershed quarter and an inflection point in the trajectory of our business," em...
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference ca...
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing ...
ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Beats Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to a loss of $0.2 per share a year ago. These f...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
